| Read Time: < 1 minute | news

Taxotere Approved for Use as Injection

December 1999 – Taxotere was approved as an injection to treat patients suffering from locally advanced or metastatic non-small cell lung cancer following failure of prior platinum-based chemotherapy. Reference: “FDA Approves New Taxotere® (Docetaxel) Injection Concentrate Formulation – Aug 5, 2010.” Sanofi, www.news.sanofi.us/press-releases?item=118530

Continue Reading

| Read Time: < 1 minute | news

Taxotere Approved for Treatment of Metastatic Breast Cancer

June 1998 – Taxotere was approved for first-line treatment of metastatic breast cancer in subjects whose disease had recurred despite adjuvant therapy. Reference: “Taxotere (Docetaxel).” CenterWatch RSS, www.centerwatch.com/directories/1067-fda-approved-drugs/listing/4266-taxotere-docetaxel

Continue Reading

| Read Time: < 1 minute | news

Taxotere Approved by FDA

May 1996 – Taxotere was approved for use by the U.S. Food & Drug Administration. Reference: “Taxotere Gets FDA Approval for Treatment of Advanced Breast Cancer.” Cancer Network, www.cancernetwork.com/view/taxotere-gets-fda-approval-treatment-advanced-breast-cancer

Continue Reading